Q-omics provides the consensus-scored RNU6-1339P profile across patient tissues and cancer cell-line models. RNU6-1339P expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in LUSC. Additionally, RNU6-1339P RNA expression shows 5,658 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LUSC, and STAD as cancer lineages where RNU6-1339P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-1339P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-1339P survival associations across molecular data types. RNU6-1339P RNA expression shows survival associations in the most cancer types (6). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-1339P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	6	LUSC (72)	view →

This table ranks reproducible RNU6-1339P RNA expression–survival associations across cancer types. High RNU6-1339P expression shows unfavorable associations in LUSC, LUAD, PAAD, LAML and LIHC, but favorable associations in STAD. The LUSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUSC as the clearest survival context for RNU6-1339P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.112	0.733	<.001	72	view →
STAD	OS	Tertile	IV	1.000	0.239	.003	36	view →
LUAD	OS	Tertile	All	0.216	0.673	.006	36	view →
PAAD	OS	Tertile	II,III,IV	0.210	0.556	.007	36	view →
LAML	DFS	Tertile	All	0.181	0.577	.024	18	view →
LIHC	DFS	Tertile	All	0.246	0.557	.049	9	view →

Pink = unfavorable, green = favorable. all 6 lineages →

RNU6-1339P-LUSC (OS)

Kaplan–Meier survival curve for RNU6-1339P RNA expression in LUSC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-1339P in patient tissues and cancer cell lines. In patient samples, RNU6-1339P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,658	STAD (5536)	view →
Protein (mass-spec)	3,080	CCRCC (709)	view →